Inari develops seed technologies that combine AI-powered predictive design with a multiplex gene editing toolbox to deliver step-change soybean, corn and wheat products. The company is singularly focused on seed technology for large-acre crops and operates an asset-light business model intended to support, not rival, seed companies. Inari reports strong performance from its first-generation products and progress toward commercialization, generating interest from seed companies both within and outside the U.S. Financially, the company completed a $144 million fundraise and has cumulative equity raised of more than $720 million. Founded by Flagship Pioneering in 2016, Inari is based in Cambridge, Mass., with additional sites in West Lafayette, Ind., and Ghent, Belgium, and employs more than 300 people. The new capital is intended to underpin long-term growth as Inari works to bring high-performing products to market at global scale. Inari develops seeds aimed at a more sustainable, nature‑positive food system by combining AI‑powered predictive design with a multiplex gene‑editing toolbox. The company intends to use the new funds to further advance its technology platform and accelerate product commercialization. Inari has a team of more than 300 employees and is led by CEO Ponsi Trivisvavet. Founded by Flagship Pioneering in 2016, the company is based in Cambridge, MA, with additional sites in West Lafayette, Ind., and Ghent, Belgium. The business recently closed a $103M funding round, bringing its total capital raised to $575M. Inari pairs AI-powered predictive design with multiplex gene editing to engineer seeds for the commercial agriculture market. The company focuses on multiplex gene-edited seed technology and advancing product development to deliver new value to growers and supply chains. It plans to use the new capital to further its technology position and expand product development efforts. Inari completed a $124M Series E equity raise and also refinanced and upsized a loan agreement to access up to $60M in debt capital. Led by CEO Ponsi Trivisvavet, the company was founded by Flagship Pioneering and has grown to more than 230 employees. Inari is based in Cambridge, Mass., with additional sites in West Lafayette, Ind., and Ghent, Belgium. Inari has developed a platform that uses predictive design and artificial intelligence to build deep understanding of genes and to design blueprints for combinations of gene‑editing tools that enable multiple edits within a single genome. Those edits produce seeds that aim to increase crop yield while reducing agriculture's footprint. The company focuses on product development for corn and soybeans in North and South America and plans to use the new funds to accelerate advancements across its science platform and product development. Inari raised $208M in a Series D that brought its cumulative equity raised to more than $352M. The round was co‑led by Flagship Pioneering with participation from Alexandria Venture Investments, Investment Corporation of Dubai, Banque Pictet (on behalf of clients), Rivas Capital, and new investors G Squared and Pavilion Capital. Founded by Flagship Pioneering in 2016, Inari is based in Cambridge, Massachusetts, with additional sites in West Lafayette, Indiana, and Ghent, Belgium. The company is led by CEO Ponsi Trivisvavet and has a team of more than 180 employees. Inari develops next-generation seeds using genetic technologies and data science. Led by CEO Ponsi Trivisvavet, the company focuses on gene-edited crops designed to reduce the natural resources required to grow food. It intends to use recent capital to accelerate development and commercialization of those gene-edited crops. The company was founded by Flagship Pioneering in 2016. Inari is headquartered in Cambridge, Mass., with additional sites in West Lafayette, Ind., and Ghent, Belgium. The company recently completed an $89M equity raise and has secured a $45M loan facility to support its plans.

Total raised

$813M

Funding rounds

8

Latest round

Equity

Latest activity

Jan 2025